Crinetics Pharmaceuticals (CRNX) Reports Q4 Loss of $0.66/sh

Crinetics Pharmaceuticals (NASDAQ: CRNX) reported Q4 EPS of ($0.66), versus ($0.60) reported last year.

For earnings history and earnings-related data on Crinetics Pharmaceuticals (CRNX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Kotak Starts INDO-MIM Ltd (INDOMIM:IN) at Reduce (3)
• B.Riley on Nayax (NYAX): 'Sell-Off Overshoots the Story'